StonvexLoading…
StonvexStonvexStonvexCore line items from MNOV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2023 2023-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|
Revenue | $409.66K | $1.00M | $4.04M |
Operating Income | $-13.28M | $-9.90M | $-10.22M |
Net Income | $-12.00M | $-8.57M | $-10.13M |
EPS (Diluted) | $-0.24 | $-0.17 | $-0.21 |
Total Assets | $45.60M | $66.27M | $87.41M |
Total Liabilities | $4.02M | $3.89M | $3.73M |
Cash & Equivalents | $30.81M | $51.00M | $71.43M |
Free Cash Flow OCF − CapEx | $-9.81M | $-7.45M | $-9.41M |
Shares Outstanding | 49.22M | 49.05M | 49.04M |